chrX-14730202-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBS2_Supporting
The NM_002063.4(GLRA2):c.1081-5G>A variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,189,623 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_002063.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLRA2 | NM_002063.4 | c.1081-5G>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000218075.9 | NP_002054.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLRA2 | ENST00000218075.9 | c.1081-5G>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_002063.4 | ENSP00000218075 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000989 AC: 11AN: 111198Hom.: 0 Cov.: 22 AF XY: 0.0000599 AC XY: 2AN XY: 33416
GnomAD3 exomes AF: 0.0000387 AC: 7AN: 180796Hom.: 0 AF XY: 0.0000152 AC XY: 1AN XY: 65616
GnomAD4 exome AF: 0.0000287 AC: 31AN: 1078425Hom.: 0 Cov.: 28 AF XY: 0.0000375 AC XY: 13AN XY: 346345
GnomAD4 genome AF: 0.0000989 AC: 11AN: 111198Hom.: 0 Cov.: 22 AF XY: 0.0000599 AC XY: 2AN XY: 33416
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at